Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil

Nephron

Volumn 82, Issue 3, 1999, Pages 232-237

  Pardo Mindan F J ^a   Errasti, P ^a   Panizo, A ^a   Sola, I ^a   De Alava, E ^a   Lozano, M D ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Apoptosis; MIB 1; Mycophenolate mofetil; Renal transplantation; TUNEL

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; FORMALDEHYDE; IMMUNOSUPPRESSIVE AGENT; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARAFFIN; PREDNISONE;

ADULT; ALLOGRAFT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLOMERULUS; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIUM; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; KIDNEY TUBULE NECROSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAINING;

ADULT; APOPTOSIS; AZATHIOPRINE; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES;

EID: 0033058907     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045407     Document Type: Article

References (26)

1. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996;61:1029-1037.
2. Robertson H, Wheeler J, Thompson V, Johnson JS, Kirby JA, Morley AR: In situ lymphoproliferation in renal transplant biopsies. Histochemistry 1995;104:331-334.
3. Shimizu A, Yamanaka N: Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:171-180.
4. Matsuno T, Sasaki H, Ishido N, Matsuda H, Sadamori H, et al: Apoptosis in human kidney allografts. Transplant Proc 1996;28:1226-1227.
5. Lieberthal W, Menza SA, Levine JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 1998;274:F315-F327.
6. Ducloux D, Fournier V, Bresson-Vautrin C, Rebibou JM, Billerey C, Saint-Hillier Y, Chalopin JM: Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: A preliminary report. Transplantation 1998;65:1504-1506.
7. Rose DSC, Maddox PH, Brown DC: Which proliferation markers for routine immunohistology? A comparison of five antibodies. J Clin Patholl 994;47:1010-1014.
8. Gonwa TA: Mycophenolate mofetil for maintenance therapy in kidney transplantation. Clin Transplant 1996;10:128-130.
9. Danovitch GM: Mycophenolate mofetil in renal transplantation: Results from US randomized trials. Kidney Int 1995;52(suppl):93-96.
10. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC: Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990;22:1659-1662.
11. Bechstein WO, Schilling M, Steele DM, Hullet DA, Sollinger HW: RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival. Transplant Proc 1993;25:702-703.
12. Ransom JT: Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995;17:681-684.
13. Nagy SE, Andersson JP, Andersson UG: Effect of mycophenolate mofetil (RS-61443) on cytokine production: Inhibition of superantigen-induced cytokines. Immunopharmacology 1993;26:11-20.
14. Halloran PF: Molecular mechanisms of new immunosuppressants. Clin Transpl 1996;10:118-123.
15. Raisanen Sokolowski A, Vuoristo P, Myllarniemi M, Yilmaz S, Kallio E, Hayry P: Mycophenolate mofetil (MMF, RS 61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transpl Immunol 1995;3:342-351.
16. Shoskes DA, Halbran PF: Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 1996;155:1831-1840.
17. Laine J, Etelamaki P, Holmberg C, Dunkel L: Apoptotic cell death in human chronic renal allograft rejection. Transplantation 1997;63:101-105.
18. Parmar MS, Kjellstrand CM, Solez K, Halloran PF: Glomerular endothelial cell detachment in paired cadaver kidney transplants: Evidence that some cadaver donors have preexisting endothelial injury. Clin Transplant 1994;8:120-127.
19. Ito H, Kasagi N, Shomori K, Osaki M, Adachi H: Apoptosis in the human allografted kidney: Analysis by terminal deoxynucleotidyl transferase-mediated DUTP-biotin nick end labeling. Transplantation 1995;60:794-798.
20. Lin Y, Benchimol S: Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol Cell Biol 1995;15:6045-6054.
21. Oyaizu N, McCloskey TW, Than S, Pahwa S: Inhibition of CD4 cross-linking-induced lymphocyte apoptosis by vesnarinone as a novel immunomodulating agent: Vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion. Blood 1996;87:2361.
22. Meehan SM, McCluskey RT, Pascual M, Preffer FI, Anderson P, Schlossman SF, Colvin RB: Cytotoxicity and apoptosis in human renal allografts: Identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest 1997;76:639-649.
23. Wang J, Nonomura N, Ichimaru N, et al: Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. J Interferon Cytokine Res 1997;17:369.
24. Boonstra JG, van der Woude FJ, Wever PC, Laterveer JC, Daha MR, van Kooten CJ: Expression and function of Fas (CD95) on human renal tubular epithelial cells. J Am Soc Nephrol 1997;8:1517-1524.
25. Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, Imagawa DK, Goss JA, Busuttil RW, Seu P: Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival. Transplantation 1998;65:155-160.
26. Kato S, Akasaka Y, Kawamura S: Fas antigen expression and its relationship with apoptosis in transplanted kidney. Pathol Int 1997;47:230-237.